Improvements in breast and prostate cancer screening have played a huge part in reducing the diseases’ mortality rates. But some say the screening has actually become too good—leading to lives being compromised by treatment for cancers that may never have become malignant.

Join our host, Isobel Marshall, as she discusses this important issue—and what’s being done about it—with breast cancer expert Associate Professor Theresa Hickey, and prostate cancer specialist Professor Lisa Butler.